Kinetics and intrapulmonary disposition of tilmicosin after single and repeated oral bolus administrations to rabbits.
G Gallina, L Lucatello, I Drigo, M Cocchi, S Scandurra, F Agnoletti, C Montesissa
Index: Vet. Res. Commun. 34 Suppl 1 , S69-72, (2010)
Full Text: HTML
Abstract
Tilmicosin (TIM, Pulmotil) was administered to eight rabbits by oral gavage at a dose of 12.5 mg/kg body weight for 2, 5, and 7 days, and its plasma kinetics and intrapulmonary disposition were investigated. TIM concentrations in plasma samples collected after days 1 and 6 of treatment were measured by high-performance liquid chromatography with ultraviolet detection. The pharmacokinetic parameters, obtained by non-compartmental analysis of TIM plasma concentrations, did not show any significant variations between days 1 and 6. From the second day of treatment, TIM concentrations attained in lung tissue and pulmonary alveolar macrophages (PAM) exceeded those in plasma by 7- and 400-fold, respectively, and high levels were maintained in lung tissues during the entire treatment duration. After the first day of withdrawal, a fast decline in TIM levels in both plasma and lung tissue was observed, but in PAM, much higher concentrations were maintained after 3 days of TIM withdrawal.
Related Compounds
Related Articles:
2013-01-01
[Water Sci. Technol. 67(8) , 1671-7, (2013)]
2011-04-01
[Vet. Microbiol. 150(1-2) , 203-6, (2011)]
Generation of reduced macrolide analogs by regio-specific biotransformation.
2011-01-01
[J. Antibiot. 64(1) , 155-7, (2011)]
Transcriptional profiling of Haemophilus parasuis SH0165 response to tilmicosin.
2012-12-01
[Microb. Drug Resist. 18(6) , 604-15, (2012)]
The controlled release of tilmicosin from silica nanoparticles.
2011-06-01
[Drug Dev. Ind. Pharm. 37(6) , 714-8, (2011)]